查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1577101

2030 年永续药品包装市场预测：按产品、材料、应用、最终用户和地区进行的全球分析

Sustainable Pharmaceutical Packaging Market Forecasts to 2030 - Global Analysis By Product (Primary Packaging, Secondary Packaging, Tertiary Packaging and Other Products), Material, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球永续药品包装市场规模为 756.2 亿美元，预计预测期内复合年增长率为 17.5%，到 2030 年将达到 1,508.6 亿美元。

永续药品包装是指设计和生产包装解决方案，最大限度地减少对环境的影响，同时确保药品的安全性、有效性和品质。永续药品包装也着重于优化包装尺寸和设计，以最大限度地减少材料使用并提高可回收性。

根据欧洲製药工业联合会和协会的数据，2021年北美占全球药品销售额的份额为49.1%，欧洲为23.4%。

企业永续性目标不断提高

製药公司正在将永续性纳入其业务策略，以满足相关人员的期望、遵守法规并提高品牌声誉。我们的目标是透过使用环保包装解决方案（包括可回收材料和生物分解性选项）来减少碳排放并最大限度地减少废弃物。这种转变不仅吸引了具有环保意识的消费者，也促进了包装设计和材料的创新。因此，企业永续性目标与市场需求之间的一致性将推动製药业永续包装解决方案的成长。

监管障碍

永续药物包装的监管障碍通常来自于管理药物包装材料的严格准则，以确保安全性、有效性和符合健康标准。这些法规可能因地区而异，从而使新的永续材料的核准流程变得复杂。此外，「可持续」的定义并不标准化，这可能会导致製造商之间的混淆。这些挑战增加了产品开发成本并延长了时间，阻碍了市场开拓。

先进材料科学与封装技术

生物分解性聚合物、植物来源材料和智慧包装解决方案等创新增强了包装的功能性和环保性能。这些材料提高了阻隔性能，确保产品的安全性和有效性，同时环保。此外，3D 列印等技术可以创建客製化且高效的包装设计，并最大限度地减少材料浪费。这种先进的包装符合监管要求和消费者偏好，从而支持製药业采用永续包装解决方案。

供应链挑战

永续药品包装的供应链挑战包括采购环保材料、控製成本和确保品质稳定。永续材料的供应有限可能会扰乱生产计划，而与传统包装相比更高的成本可能会阻碍製药公司的采用。此外，永续材料回收过程和物流的复杂性可能导致效率低下。这些挑战可能会阻碍市场成长，并最终影响竞争力，使公司难以过渡到永续实践。

COVID-19 的影响

COVID-19 大流行对永续药品包装市场产生了重大影响，加速了对环保解决方案的需求。对健康和安全的日益关注提高了人们对包装在防止污染方面作用的认识，导致一次性产品的激增。然而，这场危机促使製药公司优先考虑永续性，因为供应链中断凸显了復原能力的必要性。向电子商务的转变进一步推动了永续包装的市场开拓，以满足消费者对环保产品的偏好，并推动市场的长期成长。

预计疫苗产业在预测期内将是最大的产业。

预计疫苗领域将在整个预测期内获得最大的市场占有率。疫苗应用的永续药物包装对于确保产品完整性并尽量减少对环境的影响至关重要。环保包装材料，包括可回收和生物分解性的材料，越来越多地用于维持低温运输并防止疫苗劣化。随着疫苗宣传活动在全球扩大，采用永续包装解决方案不仅支持环境目标，也增强了大众对製药业的信任。

预计生质塑胶产业在预测期内复合年增长率最高

预计生质塑胶产业在预测期内的复合年增长率最高。由于其环保特性和减少对传统塑胶依赖的潜力，使用生质塑胶的永续药品包装正在取得进展。生质塑胶源自可再生资源，具有生物分解性并减少碳足迹。随着製药公司越来越重视永续性，生质塑胶提供了一种可行的替代方案，使包装实践与环境目标和消费者对医疗保健领域更绿色解决方案的需求保持一致。

比最大的地区

由于消费者对环境问题的意识不断提高以及永续商业实践的监管压力不断加大，预计亚太地区将在预测期内创下最大的市场占有率。日本、中国和印度等国家在采用环保包装解决方案方面处于领先地位，包括生物分解性材料和可回收材料。该地区强劲的製药业，加上包装技术的进步，进一步支持了这一趋势。此外，随着公司努力提高品牌声誉并满足消费者对绿色产品不断变化的需求，COVID-19 大流行加速了向永续实践的转变。

复合年增长率最高的地区：

由于严格的法规，预计北美在预测期内的复合年增长率最高。美国和加拿大处于采用永续实践的前沿，製药公司专注于可回收材料、生物分解性包装和减少对环境影响的创新设计。企业永续性努力和对高效供应链解决方案的需求进一步推动了市场。此外，COVID-19 大流行加速了对永续性的关注，促使公司根据消费者对环保产品不断变化的偏好来加强其包装策略。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球永续药品包装市场：副产品

  • 初级包装
    • 瓶子
    • 泡壳包装
    • 管瓶和安瓿
    • 注射器
    • 小袋
    • 小袋
  • 二次包装
    • 盒子
    • 纸盒
    • 标籤
  • 三级包装
    • 调色盘
    • 木箱
  • 其他产品

第六章全球永续药品包装市场：依材料分类

  • 玻璃
  • 金属
  • 生质塑胶
  • 纸板
  • 再生塑胶
  • 植物来源材料
  • 其他材料

第七章全球永续药品包装市场：依应用分类

  • 处方药
  • 非处方药 (OTC)
  • 食品补充品
  • 疫苗
  • 其他用途

第八章全球永续药品包装市场：依最终用户分类

  • 製药公司
  • 营养食品公司
  • 医院
  • 合约包装组织 (CPO)
  • 研发中心
  • 其他最终用户

第九章全球永续药品包装市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、合作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十一章 公司概况

  • Amcor Plc
  • Mondi Plc
  • Gerresheimer AG
  • Schott AG
  • Berry Global
  • Aptar Group
  • West Pharmaceutical Services Inc.
  • Becton, Dickinson and Company（BD）
  • Sonoco Products Company
  • Uflex Limited
  • Catalent Inc.
  • CCL Industries Inc.
  • DS Smith Plc
  • Constantia Flexibles Group GmbH
  • ALPLA Group
  • Winpak Limited
  • Piramal Glass
Product Code: SMRC27411

According to Stratistics MRC, the Global Sustainable Pharmaceutical Packaging Market is accounted for $75.62 billion in 2024 and is expected to reach $150.86 billion by 2030 growing at a CAGR of 17.5% during the forecast period. Sustainable pharmaceutical packaging refers to the design and production of packaging solutions that minimize environmental impact while ensuring the safety, efficacy, and quality of pharmaceutical products. Sustainable pharmaceutical packaging also focuses on optimizing packaging size and design to minimize material use and enhance recyclability.

According to the European Federation of Pharmaceutical Industries and Association, in 2021, North America's share of world pharmaceutical sales was 49.1%, while Europe's share was 23.4%.

Market Dynamics:

Driver:

Rising corporate sustainability goals

Pharmaceutical firms are integrating sustainability into their business strategies to meet stakeholder expectations, comply with regulations, and enhance brand reputation. By adopting eco-friendly packaging solutions, such as recyclable materials and biodegradable options, they aim to reduce their carbon footprint and minimize waste. This shift not only attracts environmentally conscious consumers but also fosters innovation in packaging design and materials. Consequently, the alignment of corporate sustainability goals with market demands propels the growth of sustainable packaging solutions in the pharmaceutical sector.

Restraint:

Regulatory hurdles

Regulatory hurdles in sustainable pharmaceutical packaging often arise from the stringent guidelines governing materials used in drug packaging, ensuring safety, efficacy, and compliance with health standards. These regulations can vary significantly across regions, complicating the approval process for new sustainable materials. Additionally, the lack of standardized definitions for "sustainable" can create confusion among manufacturers. These challenges can lead to increased costs and extended timelines for product development, hampering market growth.

Opportunity:

Advancements in materials science and packaging technologies

Innovations such as biodegradable polymers, plant-based materials, and smart packaging solutions enhance the functionality and environmental performance of packaging. These materials offer improved barrier properties, ensuring product safety and efficacy while being eco-friendly. Additionally, technologies like 3D printing enable the creation of customized, efficient packaging designs that minimize material waste. As these advancements align with regulatory requirements and consumer preferences, they drive widespread adoption of sustainable packaging solutions in the pharmaceutical sector.

Threat:

Supply chain challenges

Supply chain challenges in sustainable pharmaceutical packaging include sourcing eco-friendly materials, managing costs, and ensuring consistent quality. The limited availability of sustainable materials can disrupt production schedules, while higher costs compared to conventional packaging can deter adoption among pharmaceutical companies. Additionally, complexities in recycling processes and logistics for sustainable materials may lead to inefficiencies. These challenges can hamper market growth by making it difficult for companies to transition to sustainable practices, ultimately affecting their competitiveness.

Covid-19 Impact

The covid-19 pandemic significantly impacted the sustainable pharmaceutical packaging market by accelerating the demand for environmentally friendly solutions. Increased focus on health and safety heightened awareness of packaging's role in preventing contamination, leading to a surge in single-use products. However, the crisis also prompted pharmaceutical companies to prioritize sustainability, as supply chain disruptions highlighted the need for resilience. The shift toward e-commerce further encouraged the development of sustainable packaging to meet consumer preferences for eco-friendly products, driving long-term growth in the market.

The vaccines segment is expected to be the largest during the forecast period

The vaccines segment is predicted to secure the largest market share throughout the forecast period. Sustainable pharmaceutical packaging in vaccine applications is critical for ensuring product integrity while minimizing environmental impact. Eco-friendly packaging materials, such as recyclable and biodegradable options, are increasingly used to maintain the cold chain and protect vaccines from degradation. As vaccination campaigns expand globally, the adoption of sustainable packaging solutions not only supports environmental goals but also reinforces public trust in the pharmaceutical industry.

The bioplastics segment is expected to have the highest CAGR during the forecast period

The bioplastics segment is anticipated to witness the highest CAGR during the forecast period. Sustainable pharmaceutical packaging using bioplastics is gaining traction due to its environmentally friendly properties and potential to reduce reliance on conventional plastics. Bioplastics, derived from renewable sources offer biodegradability and reduced carbon footprints. As pharmaceutical companies increasingly prioritize sustainability, bioplastics present a viable alternative, aligning packaging practices with environmental goals and consumer demand for greener solutions in the healthcare sector.

Region with largest share:

Asia Pacific is expected to register the largest market share during the forecast period driven by rising consumer awareness of environmental issues and increasing regulatory pressure for sustainable practices. Countries like Japan, China, and India are leading the way in adopting eco-friendly packaging solutions, including biodegradable materials and recyclable options. The region's robust pharmaceutical industry, coupled with technological advancements in packaging, further fuels this trend. Additionally, the COVID-19 pandemic has accelerated the shift towards sustainable practices, as companies strive to enhance their brand reputation and meet evolving consumer demands for greener products.

Region with highest CAGR:

North America is projected to witness the highest CAGR over the forecast period due to stringent regulations. The United States and Canada are at the forefront of adopting sustainable practices, with pharmaceutical companies focusing on recyclable materials, biodegradable packaging, and innovative designs to reduce environmental impact. The market is further driven by corporate sustainability initiatives and the need for efficient supply chain solutions. Additionally, the covid-19 pandemic has accelerated the emphasis on sustainability, prompting companies to enhance their packaging strategies to align with evolving consumer preferences for eco-conscious products.

Key players in the market

Some of the key players profiled in the Sustainable Pharmaceutical Packaging Market include Amcor Plc, Mondi Plc, Gerresheimer AG, Schott AG, Berry Global, Aptar Group, West Pharmaceutical Services Inc., Becton, Dickinson and Company (BD), Sonoco Products Company, Uflex Limited, Catalent Inc., CCL Industries Inc., DS Smith Plc, Constantia Flexibles Group GmbH, ALPLA Group, Winpak Limited and Piramal Glass.

Key Developments:

In June 2024, Gerresheimer introduced EcoLine Vials as part of its commitment to sustainability in pharmaceutical packaging. These vials are manufactured using recycled glass, specifically incorporating cullet, which is recycled glass material. The EcoLine vials maintain the high-quality standards required for pharmaceutical packaging while contributing to the global effort to minimize CO2 emissions and support a circular economy.

In June 2024, Berry Global launched its EnviroTite(TM) Rigid Tubes in June 2024. These innovative tubes are designed specifically for pharmaceutical applications, incorporating up to 100% recycled content in their composition. EnviroTite(TM) provides a sustainable solution for rigid tube packaging, aligning with the global trend toward eco-friendly packaging in the healthcare sector.

Products Covered:

  • Primary Packaging
  • Secondary Packaging
  • Tertiary Packaging
  • Other Products

Materials Covered:

  • Glass
  • Metal
  • Bioplastics
  • Paper & Paperboard
  • Recycled Plastics
  • Plant-based Materials
  • Other Materials

Applications Covered:

  • Prescription Drugs
  • Over-the-Counter (OTC) Drugs
  • Nutritional Supplements
  • Vaccines
  • Other Applications

End Users Covered:

  • Pharmaceutical Companies
  • Nutraceutical Companies
  • Hospitals
  • Contract Packaging Organizations (CPOs)
  • Research & Development Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Sustainable Pharmaceutical Packaging Market, By Product

  • 5.1 Introduction
  • 5.2 Primary Packaging
    • 5.2.1 Bottles
    • 5.2.2 Blister Packs
    • 5.2.3 Vials & Ampoules
    • 5.2.4 Syringes
    • 5.2.5 Pouches
    • 5.2.6 Sachets
  • 5.3 Secondary Packaging
    • 5.3.1 Boxes
    • 5.3.2 Cartons
    • 5.3.3 Labels
  • 5.4 Tertiary Packaging
    • 5.4.1 Pallets
    • 5.4.2 Crates
  • 5.5 Other Products

6 Global Sustainable Pharmaceutical Packaging Market, By Material

  • 6.1 Introduction
  • 6.2 Glass
  • 6.3 Metal
  • 6.4 Bioplastics
  • 6.5 Paper & Paperboard
  • 6.6 Recycled Plastics
  • 6.7 Plant-based Materials
  • 6.8 Other Materials

7 Global Sustainable Pharmaceutical Packaging Market, By Application

  • 7.1 Introduction
  • 7.2 Prescription Drugs
  • 7.3 Over-the-Counter (OTC) Drugs
  • 7.4 Nutritional Supplements
  • 7.5 Vaccines
  • 7.6 Other Applications

8 Global Sustainable Pharmaceutical Packaging Market, By End User

  • 8.1 Introduction
  • 8.2 Pharmaceutical Companies
  • 8.3 Nutraceutical Companies
  • 8.4 Hospitals
  • 8.5 Contract Packaging Organizations (CPOs)
  • 8.6 Research & Development Centers
  • 8.7 Other End Users

9 Global Sustainable Pharmaceutical Packaging Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Amcor Plc
  • 11.2 Mondi Plc
  • 11.3 Gerresheimer AG
  • 11.4 Schott AG
  • 11.5 Berry Global
  • 11.6 Aptar Group
  • 11.7 West Pharmaceutical Services Inc.
  • 11.8 Becton, Dickinson and Company (BD)
  • 11.9 Sonoco Products Company
  • 11.10 Uflex Limited
  • 11.11 Catalent Inc.
  • 11.12 CCL Industries Inc.
  • 11.13 DS Smith Plc
  • 11.14 Constantia Flexibles Group GmbH
  • 11.15 ALPLA Group
  • 11.16 Winpak Limited
  • 11.17 Piramal Glass

List of Tables

  • Table 1 Global Sustainable Pharmaceutical Packaging Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Sustainable Pharmaceutical Packaging Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Sustainable Pharmaceutical Packaging Market Outlook, By Primary Packaging (2022-2030) ($MN)
  • Table 4 Global Sustainable Pharmaceutical Packaging Market Outlook, By Bottles (2022-2030) ($MN)
  • Table 5 Global Sustainable Pharmaceutical Packaging Market Outlook, By Blister Packs (2022-2030) ($MN)
  • Table 6 Global Sustainable Pharmaceutical Packaging Market Outlook, By Vials & Ampoules (2022-2030) ($MN)
  • Table 7 Global Sustainable Pharmaceutical Packaging Market Outlook, By Syringes (2022-2030) ($MN)
  • Table 8 Global Sustainable Pharmaceutical Packaging Market Outlook, By Pouches (2022-2030) ($MN)
  • Table 9 Global Sustainable Pharmaceutical Packaging Market Outlook, By Sachets (2022-2030) ($MN)
  • Table 10 Global Sustainable Pharmaceutical Packaging Market Outlook, By Secondary Packaging (2022-2030) ($MN)
  • Table 11 Global Sustainable Pharmaceutical Packaging Market Outlook, By Boxes (2022-2030) ($MN)
  • Table 12 Global Sustainable Pharmaceutical Packaging Market Outlook, By Cartons (2022-2030) ($MN)
  • Table 13 Global Sustainable Pharmaceutical Packaging Market Outlook, By Labels (2022-2030) ($MN)
  • Table 14 Global Sustainable Pharmaceutical Packaging Market Outlook, By Tertiary Packaging (2022-2030) ($MN)
  • Table 15 Global Sustainable Pharmaceutical Packaging Market Outlook, By Pallets (2022-2030) ($MN)
  • Table 16 Global Sustainable Pharmaceutical Packaging Market Outlook, By Crates (2022-2030) ($MN)
  • Table 17 Global Sustainable Pharmaceutical Packaging Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 18 Global Sustainable Pharmaceutical Packaging Market Outlook, By Material (2022-2030) ($MN)
  • Table 19 Global Sustainable Pharmaceutical Packaging Market Outlook, By Glass (2022-2030) ($MN)
  • Table 20 Global Sustainable Pharmaceutical Packaging Market Outlook, By Metal (2022-2030) ($MN)
  • Table 21 Global Sustainable Pharmaceutical Packaging Market Outlook, By Bioplastics (2022-2030) ($MN)
  • Table 22 Global Sustainable Pharmaceutical Packaging Market Outlook, By Paper & Paperboard (2022-2030) ($MN)
  • Table 23 Global Sustainable Pharmaceutical Packaging Market Outlook, By Recycled Plastics (2022-2030) ($MN)
  • Table 24 Global Sustainable Pharmaceutical Packaging Market Outlook, By Plant-based Materials (2022-2030) ($MN)
  • Table 25 Global Sustainable Pharmaceutical Packaging Market Outlook, By Other Materials (2022-2030) ($MN)
  • Table 26 Global Sustainable Pharmaceutical Packaging Market Outlook, By Application (2022-2030) ($MN)
  • Table 27 Global Sustainable Pharmaceutical Packaging Market Outlook, By Prescription Drugs (2022-2030) ($MN)
  • Table 28 Global Sustainable Pharmaceutical Packaging Market Outlook, By Over-the-Counter (OTC) Drugs (2022-2030) ($MN)
  • Table 29 Global Sustainable Pharmaceutical Packaging Market Outlook, By Nutritional Supplements (2022-2030) ($MN)
  • Table 30 Global Sustainable Pharmaceutical Packaging Market Outlook, By Vaccines (2022-2030) ($MN)
  • Table 31 Global Sustainable Pharmaceutical Packaging Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 32 Global Sustainable Pharmaceutical Packaging Market Outlook, By End User (2022-2030) ($MN)
  • Table 33 Global Sustainable Pharmaceutical Packaging Market Outlook, By Pharmaceutical Companies (2022-2030) ($MN)
  • Table 34 Global Sustainable Pharmaceutical Packaging Market Outlook, By Nutraceutical Companies (2022-2030) ($MN)
  • Table 35 Global Sustainable Pharmaceutical Packaging Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 36 Global Sustainable Pharmaceutical Packaging Market Outlook, By Contract Packaging Organizations (CPOs) (2022-2030) ($MN)
  • Table 37 Global Sustainable Pharmaceutical Packaging Market Outlook, By Research & Development Centers (2022-2030) ($MN)
  • Table 38 Global Sustainable Pharmaceutical Packaging Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.